Head-to-head · WeighScore
ElixaMD vs Harmon.Health
By GLP-1 ScorecardUpdated
Score comparison
Harmon.Health has the higher recorded score — 74/100 to 63.7/100.
Harmon.Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Harmon.Health sells compounded semaglutide and tirzepatide at one price for every dose, plus dissolving tablets and the brand Wegovy pill, but its site links to no published terms.
Before you choose
Before comparing the headline prices, the ElixaMD review and the Harmon.Health review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, ElixaMD vs No BS RX and FeelGood vs Harmon.Health compare each of them with another graded program, and the list of alternatives to ElixaMD ranks the programs closest to ElixaMD on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the System Labs review covers one graded close to these two, at 68.4/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | ElixaMD | Harmon.Health |
|---|---|---|
| WeighScore | 63.7/100 | 74/100 |
| Grade | C | C |
| Site position | #269 | #72 |
| Semaglutide | $99/mo (first month; $199/mo refills, compounded) | $149/mo (month-to-month; $389 billed quarterly or $1,249 yearly, same price at every dose, compounded) |
| Tirzepatide | Zepbound: $99 membership + medication (total not disclosed) | $199/mo (month-to-month; $499 billed quarterly or $1,599 yearly, same price at every dose, compounded) |
| Coverage | Coverage not published | All states except Mississippi |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Site position #269 · C
Strengths
- Compounded semaglutide offer states $99 for the first month and $199 for refills, including medication and shipping
- Advertises a care portal, physician guidance and ongoing support
- Names Triad Rx, RedRock Pharmacy and Beaker Pharmacy & Compounding
- Advertises Wegovy pill, Wegovy injection and Zepbound options with a separate membership charge
What to consider
- Branded medication costs are additional to the $99 membership; injection availability is qualified
- Free dietitian visits depend on insurance and copay eligibility at the visit
- Cancellation requires at least 72 hours before renewal; refund provisions have conditions
- A complete public state-availability list was not established in this review
Site position #72 · C
Strengths
- Same price at every dose, with quarterly and yearly plans
- Offers injections, dissolving tablets and the brand Wegovy pill
- Serves every state except Mississippi
What to consider
- The Terms of Service, telehealth consent and privacy notice links in the footer lead nowhere
- Neither the prescribing physicians nor the pharmacies are named
- Introductory prices run until December 1, 2026, and some prices depend on a separate club membership
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.